BTCPay Server 2.4.7 update fixes security issues, urging self-hosted merchants to upgrade immediately

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...